Systematic Financial Management LP Buys 35,165 Shares of Encompass Health Co. (NYSE:EHC)

Systematic Financial Management LP grew its stake in Encompass Health Co. (NYSE:EHC) by 8.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 461,289 shares of the company’s stock after acquiring an additional 35,165 shares during the period. Encompass Health accounts for about 1.1% of Systematic Financial Management LP’s investment portfolio, making the stock its 14th biggest position. Systematic Financial Management LP’s holdings in Encompass Health were worth $44,579,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of EHC. CIBC Asset Management Inc raised its stake in shares of Encompass Health by 3.5% during the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after buying an additional 100 shares during the last quarter. Commonwealth Equity Services LLC raised its stake in shares of Encompass Health by 1.3% during the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock worth $845,000 after buying an additional 123 shares during the last quarter. V Square Quantitative Management LLC raised its stake in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares during the last quarter. Verdence Capital Advisors LLC raised its stake in shares of Encompass Health by 4.6% during the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock worth $355,000 after buying an additional 160 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC raised its stake in shares of Encompass Health by 6.6% during the second quarter. Mount Yale Investment Advisors LLC now owns 2,749 shares of the company’s stock worth $236,000 after buying an additional 170 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Royal Bank of Canada upped their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. UBS Group upped their target price on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp upped their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Barclays upped their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Stock Performance

Shares of EHC opened at $102.37 on Thursday. Encompass Health Co. has a 12 month low of $64.15 and a 12 month high of $104.55. The firm has a fifty day simple moving average of $98.50 and a 200 day simple moving average of $91.69. The stock has a market capitalization of $10.31 billion, a price-to-earnings ratio of 24.73, a PEG ratio of 1.36 and a beta of 0.86. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.86 earnings per share. Research analysts forecast that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio is currently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.